← All diseases Autoimmune diseases

IgG4-related disease

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (21)Treatment guideline (2)Meta-analysis (1)Phase 3 study (9)Systematic review (7)Randomized trial (2)Clinical trial (63)Review article (181)Early study (phase 1 or 2) (19)Description of some patients (435)Laboratory or animal study (2)Commentary or editorial (38)Retracted publication (1) Studies currently recruiting participants only (32)

Filter

Publications and studies (1121)

• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease (2026-07-22) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases (2026-07-06) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Study of IMM0306 in IgG4-Related Disease (2026-06-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis (2026-05-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases (2026-05-18) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases (2026-05-13) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases (2026-05-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease (2026-05-08) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD (2026-05-04) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA. (2026-04-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement (2026-04-07) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Zanubrutinib in Patients With IgG4-Related Disease (2026-04-01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease (2026-02-13) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) (2026-02-05) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease (2026-02-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Institutional Registry of Rare Diseases (2026-01-14) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases (2026-01-14) ♡
• IgG4-Related Disease: Endocrine Involvement, Clinical Implications, and Management Strategies. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Idiopathic Hypertrophic Pachymeningitis with Elevated Anti-Thyroglobulin Antibodies-A Case Report. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Association Between Autoimmune Hepatitis (AIH) and Immunoglobulin G4-Related Disease (IgG4-RD) in a Male Diagnosed With Primary Sjögren's Syndrome (SJS): A Case-Based Review. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Oligocentric Castleman Disease (OligoCD): A Novel Diagnostic Entity in the Spectrum of Castleman Disease. (2025/12/29) ♡
• Features of IgG4-related sclerosing mesenteritis: A Chinese cohort study and literature review. (2025/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-related pulmonary pseudotumor and pleuritis mimicking lung cancer and asbestos plaque: A case report. (2025/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinically Isolated IgG4-Related Disease of the Larynx: A Rare Cause of Progressive Dysphonia. (2025/12/25) ♡
• Methotrexate in the Management of Laryngotracheal Stenosis: A Narrative Review. (2025/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-Related Disease With Lung and Kidney Involvement: A Case Report. (2025/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report. (2025/12/18) ♡
• Ultrasonographic features of IgG4-related kidney disease: diagnostic value and correlation with clinical-pathological findings. (2025/12/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4 Pancreatitis Presenting as a Mass: Unraveling a Diagnostic Illusion. (2025/12/12) ♡
• How Can Radiological Limitations in Atypical Clinical Submandibular Gland Küttner Tumor (IgG-4 Disease) Mimic an Atypical Occurrence of a Solid Salivary Gland Tumor? (2025/12/11) ♡
• Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study. (2025/12/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-related disease presenting with hypercalcemia: case report and mechanistic insights. (2025/12/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Atypical Presentation of IgG4-Related Disease: A Case Report of Obstructive Seminal Vesiculitis. (2025/12/08) ♡
• A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors. (2025/12/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Biopsy-Proven Cerebral Parenchymal Involvement in IgG4-Related Disease: A Case Report and a Literature Review. (2025/12/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-related disease masquerading as malignancy in the abdomen: A diagnostic challenge. (2025/12/06) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Clinical characteristics and multimodal imaging insights of coronary involvement in immunoglobulin G4-related disease. (2025/12/04) ♡
• IgG4-Related disease: From diagnosis to remission. (2025/12/01) ♡
• Clinicopathological features differentiating Castleman Disease from IgG4-related ophthalmic disease, a 10 years retrospective study. (2025/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hypophysitis. (2025/12/01) ♡
• Literature Commentary. (2025/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dual Anti-Neutrophil Cytoplasmic Antibody and Anti-Glomerular Basement Membrane Antibody-Positive Crescentic Glomerulonephritis in a Patient With Monoclonal Gammopathy and Elevated IgG4 Levels: A Case Report and Literature Review. (2025/12/01) ♡
• IgG4-Related Disease in Urological Practice: A Case Series of Mistaken Malignancies. (2025/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Rare Case of Gastric Cancer Associated with IgG4-Related Disease. (2025/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Food-related reactions in eosinophilic esophagitis: pathophysiology and treatment. (2025/12/01) ♡
• Neurological involvement in IgG4-related disease: focus on neuro-ophthalmologic features. (2025/11/26) ♡
• Protein language models uncover carbohydrate-active enzyme function in metagenomics. (2025/11/26) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors. (2025/11/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-related pleurisy with suspected asbestos involvement. (2025/11/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Aortic regurgitation and combined ventricular tachycardia due to IgG4-related disease. (2025/11/21) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.